Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
HALO:NASDAQ
Halozyme Therapeutics, Inc.
64,57 USD
+0,95%
(+0,61) 1D
64,57 USD
0,00% (0,00)
After hours
Closed: 4-май, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HALO...
Open
63,50 USD
High
64,68 USD
Low
63,11 USD
Mkt. cap
7,65 млд
Avg. vol.
1,43 млн
Volume
917,82 миң
P/E ratio
25,25
52-wk high
82,22 USD
52-wk low
47,50 USD
EPS
2,56 USD
Beta
0,89
Shares outstanding
118,47 млн
No. of employees
423
News stories
From sources across the web
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
HeadquartersСан Диего, Калифорния, Америка Кошмо Штаттары
Sector-
Websitehalozyme.com
Next call 7 күндөн кийин
11-май, дүй., 16:30
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (1,52 est.)USD
Revenue / Estimate
-/ (359,05 млн est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
264,86 млн
325,72 млн
354,26 млн
451,77 млн
Cost of goods sold
63,20 млн
46,36 млн
72,49 млн
110,67 млн
Cost of revenue
63,20 млн
46,36 млн
72,49 млн
110,67 млн
Research and development expenses
-
17,54 млн
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42,36 млн
41,61 млн
46,09 млн
63,33 млн
Operating expense
60,12 млн
76,92 млн
63,85 млн
86,70 млн
Total operating expenses
123,33 млн
123,28 млн
136,34 млн
197,37 млн
Operating income
141,54 млн
202,44 млн
217,92 млн
254,40 млн
Other non operating income
-
6,89 млн
-
-
EBT including unusual items
143,83 млн
204,94 млн
218,96 млн
-100,85 млн
EBT excluding unusual items
142,12 млн
204,94 млн
218,96 млн
251,58 млн
Income tax expense
25,73 млн
39,78 млн
43,73 млн
40,74 млн
Effective tax rate
17,89%
19,41%
19,97%
-40,40%
Other operating expenses
-
-
-
-
Net income
118,10 млн
165,16 млн
175,22 млн
-141,59 млн
Net profit margin
44,59%
50,71%
49,46%
-31,34%
Earnings per share
1,11
1,54
1,72
-0,24
Interest and investment income
5,11 млн
-
5,33 млн
2,09 млн
Interest expense
-4,52 млн
-4,39 млн
-4,30 млн
-4,91 млн
Net interest expenses
584,00 миң
-4,39 млн
1,04 млн
-2,82 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
160,48 млн
221,44 млн
236,84 млн
279,08 млн
Gain or loss from assets sale
-
-
-
2,62 млн
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer